| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis & Rheumatism 65 (11), 2737-2747, 2013 | 5046 | 2013 |
| ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus documents and the … Writing Committee Members, VV McLaughlin, SL Archer, DB Badesch, ... Circulation 119 (16), 2250-2294, 2009 | 3415 | 2009 |
| Cyclophosphamide versus placebo in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, J Goldin, MD Roth, DE Furst, ... New England Journal of Medicine 354 (25), 2655-2666, 2006 | 1882 | 2006 |
| Systemic sclerosis: a prototypic multisystem fibrotic disorder J Varga, D Abraham The Journal of clinical investigation 117 (3), 557-567, 2007 | 1512* | 2007 |
| Recent developments in myofibroblast biology: paradigms for connective tissue remodeling B Hinz, SH Phan, VJ Thannickal, M Prunotto, A Desmoulière, J Varga, ... The American journal of pathology 180 (4), 1340-1355, 2012 | 1336 | 2012 |
| Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. P Clements, P Lachenbruch, J Siebold, B White, S Weiner, R Martin, ... The Journal of rheumatology 22 (7), 1281-1285, 1995 | 1074 | 1995 |
| Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial DP Tashkin, MD Roth, PJ Clements, DE Furst, D Khanna, EC Kleerup, ... The lancet Respiratory medicine 4 (9), 708-719, 2016 | 947 | 2016 |
| Systemic sclerosis Y Allanore, R Simms, O Distler, M Trojanowska, J Pope, CP Denton, ... Nature reviews Disease primers 1 (1), 1-21, 2015 | 857 | 2015 |
| Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human … J Varga, J Rosenbloom, SA Jimenez Biochemical Journal 247 (3), 597-604, 1987 | 753 | 1987 |
| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, A Tyndall, ... Wiley Periodicals, Inc., 2013 | 677 | 2013 |
| Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. PJ Clements, PA Lachenbruch, JR Seibold, B Zee, VD Steen, P Brennan, ... The Journal of rheumatology 20 (11), 1892-1896, 1993 | 579 | 1993 |
| Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, MD Roth, DE Furst, RM Silver, ... American journal of respiratory and critical care medicine 176 (10), 1026-1034, 2007 | 572 | 2007 |
| Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study FM Wigley, RA Wise, JR Seibold, DA McCloskey, G Kujala, TA Medsger, ... Annals of internal medicine 120 (3), 199-206, 1994 | 501 | 1994 |
| Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad 3 SJ Chen, W Yuan, Y Mori, A Levenson, J Varga, M Trojanowska Journal of investigative dermatology 112 (1), 49-57, 1999 | 498 | 1999 |
| Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus TRDJ Radstake, O Gorlova, B Rueda, JE Martin, BZ Alizadeh, ... Nature genetics 42 (5), 426-429, 2010 | 449 | 2010 |
| High‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis: analysis of a two‐year, double‐blind, randomized, controlled clinical trial PJ Clements, DE Furst, WK Wong, M Mayes, B White, F Wigley, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 437 | 1999 |
| Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities S Bhattacharyya, J Wei, J Varga Nature Reviews Rheumatology 8 (1), 42-54, 2012 | 408 | 2012 |
| Scleroderma: from cell and molecular mechanisms to disease models DJ Abraham, J Varga Trends in immunology 26 (11), 587-595, 2005 | 394 | 2005 |
| Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high‐dose versus low‐dose penicillamine trial PJ Clements, EL Hurwitz, WK Wong, JR Seibold, M Mayes, B White, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 392 | 2000 |
| Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial AH Rook, B Freundlich, BV Jegasothy, MI Perez, WG Barr, SA Jimenez, ... Archives of dermatology 128 (3), 337-346, 1992 | 369 | 1992 |
Swati BhattacharyyaAssociate ProfessorPatvirtintas el. paštas northwestern.edu
